Assisted reproduction technology might boost threat of MS activity among women Researchers in Argentina record that women with multiple sclerosis who have undergo assisted reproduction technology infertility treatment are at risk for increased disease activity treatment more info . Study results released in Annals of Neurology, a journal of the American Neurological Association and Child Neurology Culture, suggest reproductive hormones donate to regulation of immune responses in autoimmune diseases such as MS. According to a 2006 record from the World Wellness Company , MS affects 2.5 million people worldwide and is more common among women than men.

Brad Webb of Claremont Creek Ventures have joined the AssureRx plank of directors, increasing table membership to seven. Burns, cEO and president of AssureRx. Their expense brings substantial strength to our medical informatics system.’ Steuart, controlling director of Claremont Creek said, ‘Capital raising firms such as ours see the chance for disruptive change springing from brand-new discoveries in individual genetics. GeneSightRx and upcoming treatment decision support products contain the promise for faster, better individual outcomes and less costly care for psychiatric conditions such as clinical depression, panic, and schizophrenia.’ Warren Hogarth, partner at Sequoia Capital, said, ‘AssureRx items possess the potential to supply significant assistance to physicians worldwide in selecting the correct medication for their patients.